Rice Z, Gooderham M, Lebwohl MG, Simpson EL, Boguniewicz M, Wollenberg A, Lazariciu I, Chan GL, Alderfer J, Watkins M. Short-Term Efficacy and Safety of Abrocitinib by Baseline Disease Severity in Patients With Moderate-to-Severe Atopic Dermatitis. J of Skin [Internet]. 2023Mar.13 [cited 2025Jan.10];7(2):s154. Available from: https://skin.dermsquared.com/skin/article/view/1980